Kazia Therapeutics Limited

(NASDAQ:kzia) Trade

By |

Equities News

Company chart and information is provided by TradingView based on 15-minute-delayed data.


Profile

Kazia Therapeutics Ltd is an oncology-focused biotechnology company, engaged in developing anti-cancer drugs. It has two clinical staged drug development candidates and an early stage discovery program.

Contact Information

Website: www.novogen.com
Email: investment.consultant@novogen.com
Main Phone: +61 294724101
Address: 300 Barangaroo Avenue
Address 2: Level 24
State: NSW
City / Town: Sydney
Country: AUS
Postal Code: 2000

Issuer Information

Exchange: NSC
CEO: James Garner
Employees: 16
Issuer Type: CS - Common Stock
Sector/Industry: Healthcare

Equities News

(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange N/A